Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Intronn

1988 FOUNDED
M&A STATUS
11-20 EMPLOYEES
M&A LATEST DEAL TYPE
5 FINANCING ROUNDS
Description

Developer of spliceosome-mediated RNA trans-splicing (SMaRT) technology. The company has produced a series of PTMs capable of base-pairing to and trans-splicing with disease associated pre-mRNA targets.

Website
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Virxsys
Primary Office
  • 910 Clopper Road
  • South Building, Suite 210
  • Gaithersburg, MD 20878
  • United States

+1 (240) 000-0000

Intronn Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Intronn‘s full profile, request access.

Request full access to PitchBook

Intronn Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Intronn‘s full profile, request access.

Request full access to PitchBook

Intronn Executive Team (1)

Name Title Board
Seat
Contact
Info
Gerard McGarrity President & Chief Executive Officer